23.06

6.60% -1.63

Nurix Therapeutics Inc (NRIX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$24.69

Aprire:

$24.86

Volume 24 ore:

1.55M

Relative Volume:

0.83

Capitalizzazione di mercato:

$2.39B

Reddito:

$71.78M

Utile/perdita netta:

$-295.28M

Rapporto P/E:

-7.2982

EPS:

-3.1597

Flusso di cassa netto:

$-271.85M

1 W Prestazione:

-3.80%

1M Prestazione:

+50.72%

6M Prestazione:

+19.48%

1 anno Prestazione:

+82.00%

Intervallo 1D:

$22.33

$24.86

Intervallo di 1 settimana:

$22.33

$24.95

Portata 52W:

$8.195

$24.95

Nurix Therapeutics Inc Stock (NRIX) Company Profile

Nome

Nurix Therapeutics Inc

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

(415) 660-5320

Indirizzo

1600 SIERRA POINT PKWY, BRISBANE

Dipendente

357

Cinguettio

Prossima data di guadagno

2026-07-08

Ultimi documenti SEC

NRIX's Discussions on Twitter

Compare NRIX vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NRIX Nurix Therapeutics Inc	23.06	2.39B	71.78M	-295.28M	-271.85M	-3.1597
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-08	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2025-11-24	Ripresa	Truist	Buy
2025-10-21	Iniziato	Mizuho	Outperform
2025-03-17	Iniziato	Leerink Partners	Market Perform
2024-12-10	Iniziato	BTIG Research	Buy
2024-12-06	Iniziato	BMO Capital Markets	Outperform
2024-10-24	Iniziato	UBS	Buy
2024-10-11	Iniziato	Jefferies	Buy
2024-09-06	Ripresa	Robert W. Baird	Outperform
2024-07-31	Iniziato	Truist	Buy
2023-06-26	Ripresa	Oppenheimer	Outperform
2023-03-09	Iniziato	Barclays	Overweight
2023-02-28	Iniziato	Oppenheimer	Outperform
2022-10-11	Iniziato	Morgan Stanley	Equal-Weight
2022-05-31	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-02-10	Iniziato	Wells Fargo	Equal Weight
2021-12-29	Iniziato	H.C. Wainwright	Buy
2021-10-14	Iniziato	SVB Leerink	Outperform
2021-06-04	Ripresa	Robert W. Baird	Outperform
2021-04-30	Ripresa	Piper Sandler	Overweight
2021-04-30	Iniziato	RBC Capital Mkts	Outperform
2021-04-14	Iniziato	Berenberg	Buy
2020-11-19	Iniziato	Robert W. Baird	Outperform
2020-08-18	Iniziato	JP Morgan	Overweight
2020-08-18	Iniziato	Needham	Buy
2020-08-18	Iniziato	Piper Sandler	Overweight
2020-08-18	Iniziato	Stifel	Buy

Mostra tutto

Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie

Jul 10, 2026

NRIX Maintained by HC Wainwright & Co. -- Price Target Raised to $34 - GuruFocus

Jul 10, 2026

Enterprise value to EBITDA forward of Nurix Therapeutics, Inc. – NASDAQ:NRIX - TradingView

Jul 10, 2026

Nurix Therapeutics, Inc. Stock 12‑Month Price Target Raised to $32.5, Implies 32% Upside - TradingView

Jul 10, 2026

NRIX Maintained by Truist Securities -- Price Target Raised to $34.00 - GuruFocus

Jul 10, 2026

RBC Capital Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $33 - Moomoo

Jul 10, 2026

A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $28 to $40 - Moomoo

Jul 10, 2026

Nurix stock price target raised to $34 by H.C. Wainwright By Investing.com - Investing.com India

Jul 10, 2026

Mizuho raises Nurix stock price target to $34 on Roche deal By Investing.com - Investing.com South Africa

Jul 10, 2026

Nurix stock price target raised to $34 by H.C. Wainwright - Investing.com UK

Jul 10, 2026

Baird reiterates Nurix stock Outperform rating at $33 target By Investing.com - Investing.com India

Jul 10, 2026

Nurix Therapeutics, Inc. Stock 12‑Month Price Target Raised to $32.25, Implies 31% Upside - TradingView

Jul 10, 2026

Russell Growth Index Additions Could Be A Game Changer For Nurix Therapeutics (NRIX) - Sahm

Jul 10, 2026

Nurix Therapeutics (NASDAQ:NRIX) Shares Down 8.6% After Earnings Miss - MarketBeat

Jul 10, 2026

Nurix Therapeutics (NASDAQ:NRIX) Price Target Raised to $40.00 - MarketBeat

Jul 10, 2026

Nurix Therapeutics (NASDAQ:NRIX) Price Target Raised to $33.00 at Royal Bank Of Canada - MarketBeat

Jul 10, 2026

NRIX Reiterates by BTIG -- Price Target Maintained at $32 - GuruFocus

Jul 10, 2026

BTIG Research Reaffirms "Buy" Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat

Jul 10, 2026

Needham & Company LLC Reiterates Buy Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat

Jul 10, 2026

RBC Capital Raises Nurix Therapeutics Price Target to $33 From $30, Maintains Outperform Speculative Risk Rating - marketscreener.com

Jul 10, 2026

Nurix Therapeutics Reports Q2 Loss, Revenue Falls Short Of Expectations - Bitcoin World

Jul 10, 2026